25.13.6
This website uses cookies to ensure you get the best experience on our website. Learn more

Long Acting Cab-LA as Pre-Exposure Prophylaxis

Cyany Kris Bukasa

WHO recommends that people at substantial risk of HIV infection should be offered PrEP. Long-Acting Cabotegravir (Cab-LA) is a safe and highly effective HIV prevention tool, as part of comprehensive approach to HIV prevention.

Skills / Knowledge

  • Pre-Exposure Prophylaxis
  • Medication adherence
  • HIV prevention
  • PrEP administration
  • Patient education
  • Clinical guidelines
  • Risk assessment

Issued on

May 23, 2025

Expires on

Does not expire